Abbott Laboratories Approved by the Food and Drug Administration For applications paired with its Continuous Glucose Monitor (CGM).
The iPhone app allows people to get glucose readings directly on their phones without using a reader. Users can scan the built-in sensors of Freestyle Libre 2 to get their current blood glucose readings and trends. They can also share glucose readings and real-time alerts with caregivers. The app has been approved for use by adults and children 4 years and older.
Abbott received a license for Freestyle Libre 2 last year.The latest CGM is designed to pair with other devices, such as its apps, and smart insulin pens, such as Developed by Bigfoot Biomedical. It uses Bluetooth signals to transmit blood glucose data every minute, and if the blood glucose level is too high or too low, the user can also set an alarm.
In other words, Abbott is not the only company hoping to establish a networked CGM in this highly competitive market.Located in San Diego Dexcom recently received FDA approval Allow other digital health applications (such as Livongo and Garmin) to connect to their data via API.company Plan to release its latest CGM, G7, later this year.
Photo Credit: Zhu Yufang, Getty Images
